Colossal Biosciences Advances Dodo Resurrection Effort
Tap title to read story
Dallas‑based Colossal Biosciences reports progress toward resurrecting the extinct dodo, the flightless bird that vanished from Mauritius in the seventeenth century. The company has filled its dodo genome to ninety‑five percent and used its GenoMorph AI platform to pinpoint genetic changes linked to the bird’s distinctive beak and facial structure. Colossal plans to edit these traits into the cells of the Nicobar pigeon, the dodo’s closest living relative. No timeline for hatching a dodo has been announced, but the firm remains committed to de‑extinction research.
More context
Timeline
- On October 14 2026 Colossal announces dodo genome ninety‑five percent complete.
- On October 14 2026 Colossal plans gene‑editing in Nicobar pigeon cells.
Why it matters
Immediate US impact: Biotech breakthrough sparks regulatory scrutiny Possible long-term US impact: Potential new conservation funding streams Most affected groups: Scientists, conservationists, island communities Reader priority: Understand scientific and ethical implications
Coverage notes
Center: Coverage from KSL.com frames this as a developing news story: Colossal Biosciences Advances Dodo Resurrection Effort. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.
Primary report
KSL.com — Colossal Biosciences Advances Dodo Resurrection Effort
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.






